InvestorsHub Logo
Followers 33
Posts 3074
Boards Moderated 0
Alias Born 02/28/2017

Re: None

Friday, 04/28/2017 4:24:20 PM

Friday, April 28, 2017 4:24:20 PM

Post# of 106839
USRM Nemesis being missed: Pharmaceutical Companies.

Do you think these companies want Stem Cell Research to succeed if "Cost savings" to the health industry? Probably not. Yes, I suppose IF approved THEN they would have interest due to basically ethical reasons, but bottom line is if cheaper, then less money for these companies to make.

Continual drugs vs. One-time procedure? Actually I'm not even sure if it would just be a "one-time" deal, but if repaired, guess it may be? I'm sure every person may react a bit different to the therapy?

C'mon RMAT!!!!